335554 <common-name>2-[[5-(4-bromophenyl)-4-(2-methylprop-2-enyl)-1,2,4-triazol-3-yl]sulfanyl]-n-[(e)-(4-ethoxyphenyl)methylideneamino]acetamide</common-name> <description>2-[[5-(4-bromophenyl)-4-(2-methylprop-2-enyl)-1,2,4-triazol-3-yl]sulfanyl]-n-[(e)-(4-ethoxyphenyl)methylideneamino]acetamide is a chemical compound with the formula C23H24BrN5O2S. With an average molecular weight of 514.40 g/mol, 2-[[5-(4-bromophenyl)-4-(2-methylprop-2-enyl)-1,2,4-triazol-3-yl]sulfanyl]-n-[(e)-(4-ethoxyphenyl)methylideneamino]acetamide is a heavy molecule.</description> <cas>330838-38-5</cas> <pubchem-id>9652349</pubchem-id> <chemical-formula>C23H24BrN5O2S</chemical-formula> <weight>514.4</weight> <appearance nil="true"/> <melting-point nil="true"/> <boiling-point nil="true"/> <density nil="true"/> <solubility nil="true"/> <specific-gravity nil="true"/> <flash-point nil="true"/> <vapour-pressure nil="true"/> <route-of-exposure nil="true"/> <target nil="true"/> <mechanism-of-toxicity nil="true"/> <metabolism nil="true"/> <toxicity nil="true"/> <lethaldose nil="true"/> <carcinogenicity nil="true"/> <use-source nil="true"/> <min-risk-level nil="true"/> <health-effects nil="true"/> <symptoms nil="true"/> <treatment nil="true"/> <created-at type="dateTime">2026-08-30T17:44:53Z</created-at> <updated-at type="dateTime">2026-08-30T17:44:53Z</updated-at> <interacting-proteins nil="true"/> <wikipedia nil="true"/> <uniprot-id nil="true"/> <kegg-compound-id nil="true"/> <omim-id nil="true"/> <chebi-id nil="true"/> <biocyc-id nil="true"/> <ctd-id nil="true"/> <stitch-id nil="true"/> <drugbank-id nil="true"/> <pdb-id nil="true"/> <actor-id nil="true"/> <organism nil="true"/> <export type="boolean">true</export> <metabolizing-proteins nil="true"/> <transporting-proteins nil="true"/> <moldb-smiles>CCOC1=CC=C(C=C1)C=NNC(=O)CSC2=NN=C(N2CC(=C)C)C3=CC=C(C=C3)Br</moldb-smiles> <moldb-formula>C23H24BrN5O2S</moldb-formula> <moldb-inchi>InChI=1S/C23H24BrN5O2S/c1-4-31-20-11-5-17(6-12-20)13-25-26-21(30)15-32-23-28-27-22(29(23)14-16(2)3)18-7-9-19(24)10-8-18/h5-13H,2,4,14-15H2,1,3H3,(H,26,30)/b25-13+</moldb-inchi> <moldb-inchikey>SEZWJQZCSWXNCC-DHRITJCHSA-N</moldb-inchikey> <moldb-average-mass type="decimal" nil="true"/> <moldb-mono-mass type="decimal">513.08341</moldb-mono-mass> <origin nil="true"/> <state nil="true"/> <logp>5.3</logp> <hmdb-id nil="true"/> <chembl-id nil="true"/> <chemspider-id nil="true"/> <structure-image-file-name nil="true"/> <structure-image-content-type nil="true"/> <structure-image-file-size type="integer" nil="true"/> <structure-image-updated-at type="dateTime" nil="true"/> <biodb-id nil="true"/> <synthesis-reference nil="true"/> <structure-image-caption nil="true"/> <chemdb-id>CHEM331447</chemdb-id> <dsstox-id nil="true"/> <toxcast-id nil="true"/> <stoff-ident-origin nil="true"/> <stoff-ident-id nil="true"/> <susdat-id nil="true"/> <iupac>2-[[5-(4-bromophenyl)-4-(2-methylprop-2-enyl)-1,2,4-triazol-3-yl]sulfanyl]-n-[(e)-(4-ethoxyphenyl)methylideneamino]acetamide</iupac> <moldb-polar-surface-area nil="true"/> <moldb-refractivity nil="true"/> <moldb-polarizability nil="true"/> <moldb-rotatable-bond-count nil="true"/> <moldb-acceptor-count nil="true"/> <moldb-donor-count nil="true"/> <moldb-pka-strongest-acidic nil="true"/> <moldb-pka-strongest-basic nil="true"/> <moldb-physiological-charge nil="true"/> <moldb-number-of-rings nil="true"/> <moldb-alogps-logp nil="true"/> <moldb-alogps-logs nil="true"/> <moldb-alogps-solubility nil="true"/> <kingdom>Organic compounds</kingdom> <superklass>Organoheterocyclic compounds</superklass> <klass>Azoles</klass> <subklass>Triazoles</subklass> <paper-count type="integer" nil="true"/> <sync-id>CED0286025</sync-id> <structure-inchikey>SEZWJQZCSWXNCC-UHFFFAOYSA-N</structure-inchikey> <structure-fingerprint>40004000000400800002000800000000000000000000000000000400000002000002000402200004000000002080000000000000000000000000200000000000000000000000000000000000000020000000000300000204800010000000000000210000000000000080000000800400880100000000002000000000420000000040000000000000000000000184880000000001000000020000000000000000008000000000000200080000000000000000480000000000002800000000000000004000000000000100004000000000000000002000000200000000000000000000800004001048000000000400000000010000000000000000004000</structure-fingerprint> <structure-pattern-fingerprint>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</structure-pattern-fingerprint> <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAgAAAAIgAAAIABBgBgAAAAAQMGAGAAAAAC AggAKAAAAAMCBkAoAAAAAwQGQGgAAAADAwEGQGgAAAADAwEGQCgAAAADBAZA aAAAAAMDAQZAaAAAAAMDAQYAaAAAAAMDAQcAKAAAAAMDBwBoAAAAAwIBBgAo AAAAAwQIACgAAAADAgYAYAAAAAICEAAgAAAAAgZAKAAAAAMEB0AoAAAAAwMH QCgAAAADAwZAKAAAAAMEB0AoAAAAAwMGAGAAAAACAgYAKAAAAAMEBgBoAAAA AwICBgBgAAAAAQMGQCgAAAADBAZAaAAAAAMDAQZAaAAAAAMDAQZAKAAAAAME BkBoAAAAAwMBBkBoAAAAAwMBIwAgAAAAAQsAAQABAgACAyADBGgMBAVoDAUG aAwGB2gMBwhoDAYJIAkKKAIKCyALDCAMDSgCDA4ADg8ADxAAEBFoDBESaAwS E2gMExRoDBQVABUWABYXCAIWGAATGSAZGmgMGhtoDBscaAwcHWgMHR5oDBwf AAgDaAwUEGgMHhloDEIDAAAABgMIBwYFBAUREBQTEgYaGxwdHhkXBAAAAAAA AAAW </structure-pickle> <structure-indexed-at type="dateTime">2026-09-19T05:37:15Z</structure-indexed-at> </compound>